Martucciello Giuseppe, Pini Prato Alessio, Puri Prem, Holschneider Alexander M, Meier-Ruge William, Jasonni Vincenzo, Tovar Juan A, Grosfeld Jay L
Department of Pediatric Surgery, IRCCS Policlinico San Matteo, Pavia I-27100, Italy.
J Pediatr Surg. 2005 Oct;40(10):1527-31. doi: 10.1016/j.jpedsurg.2005.07.053.
Intestinal Dysganglionoses (IDs) represent a heterogeneous group of Enteric Nervous System anomalies including Hirschsprung's disease (HD), Intestinal Neuronal Dysplasia (IND), Internal Anal Sphincter Neurogenic Achalasia (IASNA) and Hypoganglionosis. At present HD is the only recognised clinico-pathological entity, whereas the others are not yet worldwide accepted and diagnosed. This report describes the areas of agreement and disagreement regarding definition, diagnosis, and management of IDs as discussed at the workshop of the fourth International Meeting on "Hirschsprung's disease and related neurochristopathies." The gold standards in the preoperative diagnosis of IDs are described, enlighting the importance of rectal suction biopsy in the diagnostic workup. The most important diagnostic features of HD are the combination of hypertrophic nerve trunks and aganglionosis in adequate specimens. Acetylcholinesterase staining is the best diagnostic technique to demonstrate hypertrophic nerve trunks in lamina propia mucosae, but many pathologist from different centers still use H&E staining effectively. Moreover, the importance of an adequate intraoperative pathological evaluation of the extent of IDs to avoid postoperative complications is stressed. Although it is not clear whether IND is a separate entity or some sort of secondary acquired condition, it is concluded that both IND and IASNA do exist. Other interesting conclusions are provided as well as detailed results of the discussion. Further investigation is needed to resolve the many controversies concerning IDs. The fourth International Conference in Sestri Levante stimulated discussion regarding these entities and led to the International guidelines to serve the best interest of our patients.
肠道神经节发育异常(IDs)代表了一组异质性的肠神经系统异常,包括先天性巨结肠(HD)、肠道神经元发育异常(IND)、内括约肌神经源性失弛缓症(IASNA)和神经节减少症。目前,HD是唯一被认可的临床病理实体,而其他几种情况尚未在全球范围内被接受和诊断。本报告描述了在第四届“先天性巨结肠及相关神经发育障碍国际会议”研讨会上讨论的关于IDs的定义、诊断和管理的共识与分歧领域。阐述了IDs术前诊断的金标准,强调了直肠吸引活检在诊断检查中的重要性。HD最重要的诊断特征是在合适的标本中肥厚神经干与神经节细胞缺如并存。乙酰胆碱酯酶染色是显示黏膜固有层肥厚神经干的最佳诊断技术,但不同中心的许多病理学家仍有效地使用苏木精-伊红染色。此外,强调了对IDs范围进行充分的术中病理评估以避免术后并发症的重要性。尽管尚不清楚IND是一个独立的实体还是某种继发性获得性疾病,但得出的结论是IND和IASNA确实存在。还提供了其他有趣的结论以及详细的讨论结果。需要进一步研究以解决有关IDs的诸多争议。在塞斯特里莱万特召开的第四届国际会议激发了关于这些实体的讨论,并产生了符合我们患者最佳利益的国际指南。